• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 7, 2011

View Archived Issues

Biologics Manufacturing Grows, But Small Firms Won't Benefit

GLASGOW, SCOTLAND – The global capacity for manufacturing biologics is growing, but most facilities are controlled by a few major companies and used for their own products, creating difficulties for smaller biotechs with products that are approaching commercialization. Read More

UK Launches $282M Program For Life Sciences Innovation

LONDON – A £180 million (US$282 million) three-year program to bridge the ever-growing funding gap between university research and commercialization has been launched by the UK government as the centerpiece of a new strategy for the life sciences, announced by prime minister David Cameron on Monday. Read More

Targets Flow from Genomewide Study of Blood Formation Genes

LONDON – A slew of genes involved in the development of blood cells could become new targets for therapies to treat a whole range of conditions, from inherited blood clotting disorders and anemia to thrombotic events, including myocardial infarction. Read More

TopiVert Getting $12.5M for Topical Kinase Inhibitors

Two of the investors behind RespiVert Ltd., which was acquired by Johnson & Johnson subsidiary Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.) last year are hoping to repeat the success with a sequel. Imperial Innovations Group plc and SV Life Sciences are committing up to £8 million (US$12.5 million) to TopiVert Ltd., a new start-up focused on the discovery of topical kinase inhibitors for inflammatory conditions of the eye and gut. Read More

EC Aims to Increase R&D Spend from $74B to $107B

LONDON – The European Commission confirmed its plans to increase spending on research and development from €55 billion (US$74.1 billion) in the current seven-year program to €80 billion from 2014 through 2020, and said that €8 billion would go directly to small companies. In parallel, a new scheme to support research-based start-ups worth a further €2.5 billion was announced. Read More

ArGen-X Brings in $37M for Conventional Camelid Antibodies

ArGen-X BV raised €27.5 million (US$37.1 million) in a Series B round to move its first two programs into clinical development. Read More

MacroGenics 'Serves' Early Stage Antibody Deal: Potential $450M

In a potential $450 million deal, MacroGenics Inc. has signed up the privately held French pharmaceutical company Servier as partner for MGA271, a first-in-class antibody targeting B7-H3, an antigen that is expressed in a long and growing list of solid tumors. Read More

Other News To Note

• Genetic Technologies Ltd., of Melbourne, Australia, said it executed a settlement and license agreement granting AutoImmun Diagnostika GmbH, of Strassberg, Germany, nonexclusive rights to a number of its patents relating to noncoding DNA technology. Financial terms were not disclosed. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe